Neurological Disorders studies
ASCEND Clinical Trial
A clinical trial to study the efficacy of natalizumab on reducing disability progression in subjects with secondary progressive multiple sclerosis.
Cholesterol-lowering medication as risk factors for amyotrophic lateral sclerosis
The primary objective of this study is to investigate whether the use of cholesterol-lowering medications increases the risk of developing ALS or influences the rate of disease progression among individuals who have ALS.
Medical Expenditure Panel Survey (MEPS)
The aim of this study is to verify the cost of care for persons with multiple sclerosis.
Multiple sclerosis clinical care physician fellowship program
Training and mentoring of resident in treatment of multiple sclerosis.
Principal Investigator:Annette M. Langer-Gould, MD, PhD, MS
Funding Source:National Multiple Sclerosis Society (NMSS)
Funding Years:2013 - 2014
Research Categories:Neurological Disorders
Zoster Vaccine and Risk Factors of Zoster and Post-Herpetic Neuralgia
The aims of the study are to determine the incidence of reactivation of Oka strain VZV in community-dwelling persons vaccinated with zoster vaccines; to test clinical isolates for evidence of recombination between vaccine and wild-type strains VZV; to identify risk factors of HZ among individuals vaccinated with zoster vaccines; to identify risk factors for post-herpetic neuralgia (PHN) among HZ cases who were either vaccinated or unvaccinated with zoster vaccines, and to compare the clinical manifestations and risk of PHN between vaccinated and unvaccinated individuals.